Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stock To Watch: APA, BYND, INMD, PERI, SPNS, SYRS

Published 01/08/2020, 03:26 AM
Updated 07/09/2023, 06:31 AM

1. Apache Corporation (NYSE:APA) was up 6.87, or 27%, to 32.51, closing just pennies off the 32.58 high, on 36.5 million shares on Tuesday. That may be the biggest volume ever seen on this stock. It had a major oil discovery of the northeast coast of South America, the biggest gain in nearly 50 years. This stock, which was wedging, exploded and closed at the high end of the range going away. I expect, with that kind of move and that kind of volume, we’ll see a follow-through. My target is 38-39.

2. Beyond Meat (NASDAQ:BYND) had a big pop as their major rival, Impossible Foods, not able to be a McDonald’s (NYSE:MCD) supplier, dropped out of the race on Tuesday. BYND jumped 9.30, or 12 1/2%, to 83.89, on nearly 12 million shares. It traded an early morning low of 75.03, ran up to the high near my target zone at 85 to 84.88, and pulled back. This might be a breakaway move, so we’ll have to see if there’s a follow-through. Key, short-term resistance is 90. Beyond that we’re looking at 97-98, and then 110-111.

3. InMode (NASDAQ:INMD) pullback was more than I wanted to see, but it did reverse on Tuesday, and ran 2.97, or 8.48%, to 38.01, reaching 38.89, on 1.6 million shares. Again, we’ll have to see if there’s a follow-through. If it does, for starters I want to see it take out 40 1/2, and then blow through 45. Those are my near-term targets. It could go much higher with volume.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

4. Perion (NASDAQ:PERI) is trending, surging with volume, and broke out above the Aug high. Now, it’s in a channel, which tells me it might accelerate. On Tuesday, it popped 46 cents, or 6.43%, to 7.76, not far off the high at 7.86, on 758,103 shares traded. Targets going forward are 10 and 12.

5. Sapiens International (NASDAQ:SPNS) has been in a beautiful uptrend for over a year, and with the breakout on Tuesday out of a two-month flag, it ran up 1.48, or 6.37%, to 24.73, reaching 24.98, on 111,793 shares traded. I think this stock is going to 27.

6. Syros Pharmaceuticals (NASDAQ:SYRS) exploded three weeks ago, pulled back in a coil, and got very tight and very quiet, until Tuesday when it popped 44 cents, or 6.34%, to 7.38, not far off the 7.44 high, on 281,815 shares traded. I think it might be the beginning of a move, with targets of 8 1/2 and then 10-10 1/2.

Stocks on the long side included Apache Corporation (NYSE:APA), Apellis Pharmaceuticals, Inc. (APLS), Aurinia Pharmaceuticals Inc. (AUPH), Beyond Meat, Inc. (NASDAQ:BYND), Covetrus, Inc. (CVET), Bitcoin Investment Trust (GBTC), Himax Technologies, Inc. (HIMX), InMode Ltd. (INMD), Inseego Corp. (INSG), Inphi Corporation (IPHI), Kiniksa Pharmaceuticals, Ltd. (KNSA), Lattice Semiconductor Corporation (LSCC), Micron Technology, Inc. (NASDAQ:MU), O-I Glass, Inc. (OI), Perion Network Ltd. (PERI), Purple Innovation, Inc. (PRPL), Sapiens International Corporation N.V. (SPNS), Stage Stores, Inc. (SSI), Syros Pharmaceuticals, Inc. (SYRS), TG Therapeutics, Inc. (TGTX), Weight Watchers International I (WW), and Xenon Pharmaceuticals Inc. (XENE).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here...

Latest comments

Thank you
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.